Article
Messenger RNA therapy for rare genetic metabolic diseases
22 Feb 2019
Abstract excerpt
Decades of intense research in molecular biology and biochemistry are fructifying in the emergence of therapeutic messenger RNAs (mRNA) as a new class of drugs. Synthetic mRNAs can be sequence optimised to improve translatability into proteins, as well as chemically modified to reduce immunogenicity and increase chemical stability using naturally occurring uridine modifications. These structural improvements,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
